GMAB:CPH
Genmab A/S
2 487,00 DKK
arrow_upward
+1,72%(+42,00) 1D
12 հոկ, 17:00:00 GMT+2 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GMAB...
Open
2 468,00 DKK
High
2 504,00 DKK
Low
2 459,00 DKK
Mkt. cap
152,72 մլրդ
Avg. vol.
128,35 հզր
Volume
105,44 հզր
52-wk high
2 603,00 DKK
52-wk low
1 512,00 DKK
Shares outstanding
62,41 մլն
No. of employees
3 հզր
Open
2 468,00 DKK
High
2 504,00 DKK
Low
2 459,00 DKK
Mkt. cap
152,72 մլրդ
Avg. vol.
128,35 հզր
Volume
105,44 հզր
52-wk high
2 603,00 DKK
52-wk low
1 512,00 DKK
Shares outstanding
62,41 մլն
No. of employees
3 հզր
News stories
From web sources and news partners
New York Post
·
2 ժամ առաջ
NYSE's opening bell honors Italian Americans who beat stereotypes to reach pinnacle of finance
Simply Wall Street
·
1 ժամ առաջ
What Does Microsoft (MSFT) Gain From Its New Maia 300 AI Chip?
https://tech-insider.org/
·
1 ժամ առաջ
Nasdaq Slips 0.2%, Oil Jumps 2% on Ukraine Strikes [2026]
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S
CEOJan G. J. van de Winkel
Employees3,12 հզր
Founded11 հնս, 1998 թ.
Headquarters-
Sector-
Websitegenmab.com